Nanoform Finland Oyj (NANOFH.HE)
EUR 1.29
(2.7%)
EUR 1.29
(2.7%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -20.75 Million EUR | 5.98% |
| 2022 | -22.07 Million EUR | -12.11% |
| 2021 | -19.68 Million EUR | -1.28% |
| 2020 | -19.44 Million EUR | -152.73% |
| 2019 | -7.69 Million EUR | -270.85% |
| 2018 | -2.07 Million EUR | -297.93% |
| 2017 | -521.27 Thousand EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.96 Million EUR | -30.5% |
| 2024 Q2 | -5.23 Million EUR | 24.8% |
| 2023 Q3 | -4.12 Million EUR | 39.42% |
| 2023 Q1 | -4.49 Million EUR | 19.35% |
| 2023 Q4 | -5.33 Million EUR | -29.52% |
| 2023 FY | -20.75 Million EUR | 5.98% |
| 2023 Q2 | -6.8 Million EUR | -51.5% |
| 2022 Q3 | -5.15 Million EUR | 14.92% |
| 2022 FY | -22.07 Million EUR | -12.11% |
| 2022 Q4 | -5.56 Million EUR | -8.03% |
| 2022 Q2 | -6.05 Million EUR | -14.45% |
| 2022 Q1 | -5.29 Million EUR | 4.9% |
| 2021 Q1 | -4.27 Million EUR | -8.34% |
| 2021 Q3 | -4.51 Million EUR | 15.49% |
| 2021 Q4 | -5.56 Million EUR | -23.35% |
| 2021 Q2 | -5.34 Million EUR | -25.06% |
| 2021 FY | -19.68 Million EUR | -1.28% |
| 2020 FY | -19.44 Million EUR | -152.73% |
| 2020 Q4 | -3.94 Million EUR | 5.14% |
| 2020 Q3 | -4.15 Million EUR | 38.52% |
| 2020 Q2 | -6.75 Million EUR | -47.3% |
| 2020 Q1 | -4.58 Million EUR | -77.04% |
| 2019 Q1 | -1.14 Million EUR | 0.0% |
| 2019 Q4 | -2.59 Million EUR | -19.42% |
| 2019 FY | -7.69 Million EUR | -270.85% |
| 2019 Q3 | -2.17 Million EUR | -31.75% |
| 2019 Q2 | -1.64 Million EUR | -43.97% |
| 2018 FY | -2.07 Million EUR | -297.93% |
| 2017 FY | -521.27 Thousand EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Biohit Oyj | 1.85 Million EUR | 1221.333% |
| Herantis Pharma Oyj | 279.84 Thousand EUR | 7517.05% |